Better Response, Survival in Head and Neck Cancer With Dual Pre-Op Immunotherapy

[ad_1]

(MedPage Today) — Two neoadjuvant immunotherapy combinations for head and neck cancer substantially increased the response rate versus a single drug, a small randomized trial showed.
The pathologic tumor response (pTR) rate increased from 41…

[ad_2]

Source link : https://www.medpagetoday.com/hematologyoncology/othercancers/114724

Author :

Publish date : 2025-03-18 21:35:00

Copyright for syndicated content belongs to the linked Source.